GMED Stock May Benefit Following the Acquisition of Nevro

Company Overview - Globus Medical, Inc. (GMED) has completed the acquisition of Nevro Corp., enhancing its position in the musculoskeletal market [1] - The acquisition is expected to unlock a market opportunity valued at $2.50 billion [4] Financial Performance - Globus Medical has a market capitalization of $9.47 billion, with projected revenues for 2025 expected to increase by 6.5% year over year [3] - Following the acquisition, net sales projections for 2025 are estimated to be between $2.80 billion and $2.90 billion, an increase from previous estimates of $2.66 billion to $2.69 billion [6] Market Trends - The global orthopedic devices market was valued at $59.4 billion in 2023, with a projected compound annual growth rate of 5.3% through 2032, driven by factors such as the rising prevalence of osteoporosis and musculoskeletal diseases [7] Recent Developments - Globus Medical recently launched the COHERE ALIF Spacer, a new product designed for anterior lumbar interbody fusion surgery, along with Modulus ALIF Blades, expanding its product offerings [9] Stock Performance - Since the acquisition announcement on April 3, shares of Globus Medical have decreased by 4.6%, closing at $72.02 [2] - Over the past year, GMED shares have increased by 29.5%, contrasting with an 18.8% decline in the industry [10]